select a format

Single User License
USD 250 INR 16198
Site License
USD 500 INR 32395
Corporate User License
USD 750 INR 48593

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


ValiRx Plc (VAL)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

ValiRx Plc (VAL)-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH58208D
  • |
  • Pages: 44
  • |
  • May 2017
  • |
  • |
  Request for Sample Report

Executive Summary

Summary

ValiRx Plc (ValiRx) is a biopharmaceutical company that develops technologies and therapeutic options for the treatment of cancer. The company's products and technology include GeneICE-silencing rebellious genes, GeneICE-BCL-2, VAL201-prostate cancer, NAV3 cancer screening test and VAL401-lung cancer. It operates through its three business divisional companies. ValiRx's ValiMedix sells and distributes oncology therapeutics. The company's ValiPharma is a therapeutics division that provides technologies for the treatment of cancer. Its's ValiFinn offers research and development services. The company also develops clinical trials used to treat hormone induced refractory prostate cancer and other conditions of hormone. ValiRx is headquartered in London, the UK.

ValiRx Plc (VAL)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

ValiRx Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

ValiRx Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

ValiRx Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

ValiRx Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

ValiRx Plc, Medical Devices Deals, 2011 to YTD 2017 10

ValiRx Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11

ValiRx Plc, Pharmaceuticals & Healthcare, Deal Details 12

Asset Purchase 12

ValiRx Acquires TRAC Biomarker Technology for USD1 Million 12

Partnerships 12

ValiRx Enters into Co-Development Agreement with Pharmatest Services 12

ValiRx Enters into Agreement with German Cancer Research Center for VAL-101 13

ValiRx Forms Joint Venture With Tangent Reprofiling 14

ValiRx Enters Into Co-Development Agreement With Imperial College London 15

ValiRx Enters Into Co-Development Agreement With Oxford University 16

Equity Offering 17

Valirx Raises Funds in Private Placement of Shares 17

Valirx Raises USD1.4 Million in Private Placement of Shares 18

ValiRx Raises USD0.7 Million in Private Placement of Shares 19

ValiRx Raises USD3.8 Million in Private Placement of Shares 20

ValiRx Raises USD1.2 Million in Private Placement of Shares 21

ValiRx Completes Private Placement of Shares for USD1.3 Million 22

ValiRx Completes Private Placement Of Shares For US$4.75 Million 23

ValiRx Completes Private Placement Of Shares For US$1.6 Million 25

ValiRx Completes Private Placement Of Shares For 1.4 Million 25

ValiRx Completes Private Placement Of US$4.94 Million 26

Acquisition 27

ValiRx Divests Its Stake In VolitionRx For US$0.6 Million 27

ValiRx Plc-Key Competitors 29

Key Employees 30

Locations And Subsidiaries 31

Head Office 31

Other Locations & Subsidiaries 31

Recent Developments 32

Financial Announcements 32

May 05, 2017: ValiRx: Final Results for the Year Ended 31 December 2016 32

Sep 27, 2016: ValiRx: Half Yearly Report for the Period Ended 30 June 2016 35

May 19, 2016: VALIRX: Final Results for the Year Ended 31 December 2015 37

Other Significant Developments 40

Apr 18, 2017: ValiRx: Change of Registered Office 40

Sep 13, 2016: ValiRx: Quarterly Update On Clinical Developments 41

Jun 07, 2016: ValiRx: Quarterly Update On Clinical Developments 42

Feb 09, 2016: ValiRx: Quarterly Update on Clinical Progress 43

Appendix 44

Methodology 44

About GlobalData 44

Contact Us 44

Disclaimer 44

List of Figures

ValiRx Plc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

ValiRx Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

ValiRx Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

ValiRx Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

ValiRx Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

ValiRx Plc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7

ValiRx Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

ValiRx Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

ValiRx Plc, Medical Devices Deals, 2011 to YTD 2017 10

List of Tables

ValiRx Plc, Pharmaceuticals & Healthcare, Key Facts, 2015 1

ValiRx Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

ValiRx Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

ValiRx Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

ValiRx Plc, Deals By Therapy Area, 2011 to YTD 2017 9

ValiRx Plc, Medical Devices Deals, 2011 to YTD 2017 10

ValiRx Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11

ValiRx Acquires TRAC Biomarker Technology for USD1 Million 12

ValiRx Enters into Co-Development Agreement with Pharmatest Services 12

ValiRx Enters into Agreement with German Cancer Research Center for VAL-101 13

ValiRx Forms Joint Venture With Tangent Reprofiling 14

ValiRx Enters Into Co-Development Agreement With Imperial College London 15

ValiRx Enters Into Co-Development Agreement With Oxford University 16

Valirx Raises Funds in Private Placement of Shares 17

Valirx Raises USD1.4 Million in Private Placement of Shares 18

ValiRx Raises USD0.7 Million in Private Placement of Shares 19

ValiRx Raises USD3.8 Million in Private Placement of Shares 20

ValiRx Raises USD1.2 Million in Private Placement of Shares 21

ValiRx Completes Private Placement of Shares for USD1.3 Million 22

ValiRx Completes Private Placement Of Shares For US$4.75 Million 23

ValiRx Completes Private Placement Of Shares For US$1.6 Million 25

ValiRx Completes Private Placement Of Shares For 1.4 Million 25

ValiRx Completes Private Placement Of US$4.94 Million 26

ValiRx Divests Its Stake In VolitionRx For US$0.6 Million 27

ValiRx Plc, Key Competitors 29

ValiRx Plc, Key Employees 30

ValiRx Plc, Other Locations 31

ValiRx Plc, Subsidiaries 31

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

ValiRx Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com